GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,902.2 Cr | -5.8% | -1.6% | -14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -5.8% |
-1.6% |
-14.3% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses